Impact of EGFR tyrosine kinase inhibitors versus chemotherapy on the development of leptomeningeal metastasis in never smokers with advanced adenocarcinoma of the lung.

Lee, Youngjoo; Han, Ji-Youn; Kim, Heung Tae; Yun, Tak; Lee, Geon Kook; Kim, Hyae Young; Lee, Jin Soo

Lee, Youngjoo; Han, Ji-Youn; Kim, Heung Tae; Yun, Tak; Lee, Geon Kook; Kim, Hyae Young; Lee, Jin Soo.

Affiliation

Lee Y; Center for Lung Cancer, National Cancer Center, Ilsanro 323, Ilsandong-gu, Goyang, Gyeonggi, 410-769, Republic of Korea.

J Neurooncol ; 115(1): 95-101, 2013 Oct.

Article in En | MEDLINE | ID: mdl-23832498

Subject(s)

Adenocarcinoma/secondary; Antineoplastic Combined Chemotherapy Protocols/therapeutic use; ErbB Receptors/antagonists & inhibitors; Lung Neoplasms/pathology; Meningeal Neoplasms/secondary; Protein Kinase Inhibitors/therapeutic use; Quinazolines/therapeutic use; Adenocarcinoma/drug therapy; Aged; Cisplatin/administration & dosage; Deoxycytidine/administration & dosage; Deoxycytidine/analogs & derivatives; Disease Progression; Female; Follow-Up Studies; Gefitinib; Humans; Lung Neoplasms/drug therapy; Male; Neoplasm Staging; Prognosis; Survival Rate; Gemcitabine

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Quinazolines / Adenocarcinoma / Antineoplastic Combined Chemotherapy Protocols / Protein Kinase Inhibitors / ErbB Receptors / Lung Neoplasms / Meningeal Neoplasms Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male Language: En Journal: J Neurooncol Year: 2013 Type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google